Characterization of the chemokine response of RAW264.7 cells to infection by murine norovirus

Virus Research

Volumn 181, Issue , 2014, Pages 27-34

  Waugh, Emily ^a   Chen, Augustine ^a   Baird, Margaret A ^a,b   Brown, Chris M ^a   Ward, Vernon K ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Calicivirus; Chemokines; Immunity; Norovirus

Indexed keywords

CALICIVIRUS; CHEMOKINES; IMMUNITY; NOROVIRUS;

ANIMALS; CELL LINE; CELLS, CULTURED; CHEMOKINES; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INTERFERONS; MACROPHAGES; MICE; NOROVIRUS; UP-REGULATION; VIRUS REPLICATION;

EID: 84893830343     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2013.12.025     Document Type: Article

References (53)

1. Annunziato F., Cosmi L., Galli G., Beltrame C., Romagnani P., Manetti R., Romagnani S., Maggi E. Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo. J. Leukoc. Biol. 1999, 65(5):691-699.
2. Belliot G., Lavaux A., Souihel D., Agnello D., Pothier P. Use of murine norovirus as a surrogate to evaluate resistance of human norovirus to disinfectants. Appl. Environ. Microbiol. 2008, 74(10):3315-3318.
3. Bok K., Parra G.I., Mitra T., Abente E., Shaver C.K., Boon D., Engle R., Yu C., Kapikian A.Z., Sosnovtsev S.V., Purcell R.H., Green K.Y. Chimpanzees as an animal model for human norovirus infection and vaccine development. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(1):325-330.
4. Bok K., Prikhodko V.G., Green K.Y., Sosnovtsev S.V. Apoptosis in murine norovirus-infected RAW264.7 cells is associated with downregulation of survivin. J. Virol. 2009, 83(8):3647-3656.
5. Cantini G., Pisati F., Pessina S., Finocchiaro G., Pellegatta S. Immunotherapy against the radial glia marker GLAST effectively triggers specific antitumor effectors without autoimmunity. Oncoimmunology 2012, 1(6):884-893.
6. Caux C., Ait-Yahia S., Chemin K., de Bouteiller O., Dieu-Nosjean M.C., Homey B., Massacrier C., Vanbervliet B., Zlotnik A., Vicari A. Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin. Immunopathol. 2000, 22(4):345-369.
7. Chachu K.A., LoBue A.D., Strong D.W., Baric R.S., Virgin H.W. Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection. PLoS Pathog. 2008, 4(12):e1000236.
8. Changotra H., Jia Y., Moore T.N., Liu G., Kahan S.M., Sosnovtsev S.V., Karst S.M. Type I and type II interferons inhibit the translation of murine norovirus proteins. J. Virol. 2009, 83(11):5683-5692.
9. Cole K.E., Strick C.A., Paradis T.J., Ogborne K.T., Loetscher M., Gladue R.P., Lin W., Boyd J.G., Moser B., Wood D.E., Sahagan B.G., Neote K. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J. Exp. Med. 1998, 187(12):2009-2021.
10. Deshmane S.L., Kremlev S., Amini S., Sawaya B.E. Monocyte chemoattractant protein-1 (MCP-1): an overview. J. Interferon Cytokine Res. 2009, 29(6):313-326.
11. Duizer E., Schwab K.J., Neill F.H., Atmar R.L., Koopmans M.P., Estes M.K. Laboratory efforts to cultivate noroviruses. J. Gen. Virol. 2004, 85(Pt 1):79-87.
12. Eppig J.T., Blake J.A., Bult C.J., Kadin J.A., Richardson J.E. The Mouse Genome Database (MGD): comprehensive resource for genetics and genomics of the laboratory mouse. Nucleic Acids Res. 2012, 40(D1):D881-D886. Mouse Genome Database Group.
13. Estes M.K., Prasad B.V., Atmar R.L. Noroviruses everywhere: has something changed?. Curr. Opin. Infect. Dis. 2006, 19(5):467-474.
14. Gonzalez-Hernandez M.B., Bragazzi Cunha J., Wobus C.E. Plaque assay for murine norovirus. J. Vis. Exp. 2012, 66:e4297.
15. Griener T.P., Strecker J.G., Humphries R.M., Mulvey G.L., Fuentealba C., Hancock R.E., Armstrong G.D. Lipopolysaccharide renders transgenic mice expressing human serum amyloid P component sensitive to Shiga toxin 2. PLoS ONE 2011, 6(6):e21457.
16. Groom J.R., Luster A.D. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol. Cell Biol. 2011, 89(2):207-215.
17. Hochrainer K., Racchumi G., Anrather J. Site-specific phosphorylation of the p65 protein subunit mediates selective gene expression by differential NF-kappaB and RNA polymerase II promoter recruitment. J. Biol. Chem. 2013, 288(1):285-293.
18. Huang da W., Sherman B.T., Lempicki R.A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009, 37(1):1-13.
19. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4(1):44-57.
20. Karst S.M., Wobus C.E., Lay M., Davidson J., Virgin H.W.t. STAT1-dependent innate immunity to a Norwalk-like virus. Science 2003, 299(5612):1575-1578.
21. Khan I.A., MacLean J.A., Lee F.S., Casciotti L., DeHaan E., Schwartzman J.D., Luster A.D. IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity 2000, 12(5):483-494.
22. Kim K.I., Zhang D.E. ISG15, not just another ubiquitin-like protein. Biochem. Biophys. Res. Commun. 2003, 307(3):431-434.
23. Lateef Z., Baird M.A., Wise L.M., Mercer A.A., Fleming S.B. Orf virus-encoded chemokine-binding protein is a potent inhibitor of inflammatory monocyte recruitment in a mouse skin model. J. Gen. Virol. 2009, 90(Pt 6):1477-1482.
24. Lateef Z., Baird M.A., Wise L.M., Young S., Mercer A.A., Fleming S.B. The chemokine-binding protein encoded by the poxvirus orf virus inhibits recruitment of dendritic cells to sites of skin inflammation and migration to peripheral lymph nodes. Cell. Microbiol. 2010, 12(5):665-676.
25. Lindesmith L., Moe C., Lependu J., Frelinger J.A., Treanor J., Baric R.S. Cellular and humoral immunity following Snow Mountain virus challenge. J. Virol. 2005, 79(5):2900-2909.
26. LoBue A.D., Lindesmith L.C., Baric R.S. Identification of cross-reactive norovirus CD4+ T cell epitopes. J. Virol. 2010, 84(17):8530-8538.
27. Loo Y.M., Fornek J., Crochet N., Bajwa G., Perwitasari O., Martinez-Sobrido L., Akira S., Gill M.A., Garcia-Sastre A., Katze M.G., Gale M. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 2008, 82(1):335-345.
28. Lu X., Jin T., Jin Y., Wu L., Hu B., Tian Y., Fan X. Toxicogenomic analysis of the particle dose- and size-response relationship of silica particles-induced toxicity in mice. Nanotechnology 2013, 24(1):015106.
29. Luttichau H.R. The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist. J. Biol. Chem. 2010, 285(12):9137-9146.
30. Maurer M., von Stebut E. Macrophage inflammatory protein-1. Int. J. Biochem. Cell Biol. 2004, 36(10):1882-1886.
31. McCartney S.A., Thackray L.B., Gitlin L., Gilfillan S., Virgin H.W., Colonna M. MDA-5 recognition of a murine norovirus. PLoS Pathog. 2008, 4(7):e1000108.
32. McFadden N., Bailey D., Carrara G., Benson A., Chaudhry Y., Shortland A., Heeney J., Yarovinsky F., Simmonds P., Macdonald A., Goodfellow I. Norovirus regulation of the innate immune response and apoptosis occurs via the product of the alternative open reading frame 4. PLoS Pathog. 2011, 7(12):e1002413.
33. Mortier A., Van Damme J., Proost P. Regulation of chemokine activity by posttranslational modification. Pharmacol. Ther. 2008, 120(2):197-217.
34. Mumphrey S.M., Changotra H., Moore T.N., Heimann-Nichols E.R., Wobus C.E., Reilly M.J., Moghadamfalahi M., Shukla D., Karst S.M. Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses. J. Virol. 2007, 81(7):3251-3263.
35. O'Garra A., McEvoy L.M., Zlotnik A. T-cell subsets: chemokine receptors guide the way. Curr. Biol. 1998, 8(18):R646-R649.
36. Ohoka Y., Yokota A., Takeuchi H., Maeda N., Iwata M. Retinoic acid-induced CCR9 expression requires transient TCR stimulation and cooperativity between NFATc2 and the retinoic acid receptor/retinoid X receptor complex. J. Immunol. 2011, 186(2):733-744.
37. Patel M.M., Hall A.J., Vinje J., Parashar U.D. Noroviruses: a comprehensive review. J. Clin. Virol. 2009, 44(1):1-8.
38. Perry J.W., Taube S., Wobus C.E. Murine norovirus-1 entry into permissive macrophages and dendritic cells is pH-independent. Virus Res. 2009, 143(1):125-129.
39. Platanias L.C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 2005, 5(5):375-386.
40. Reich M., Liefeld T., Gould J., Lerner J., Tamayo P., Mesirov J.P. GenePattern 2.0. Nat. Genet. 2006, 38(5):500-501.
41. Sallusto F., Baggiolini M. Chemokines and leukocyte traffic. Nat. Immunol. 2008, 9(9):949-952.
42. Sharp T.M., Guix S., Katayama K., Crawford S.E., Estes M.K. Inhibition of cellular protein secretion by Norwalk virus nonstructural protein p22 requires a mimic of an endoplasmic reticulum export signal. PLoS ONE 2010, 5(10):e13130.
43. Sillanpaa M., Kaukinen P., Melen K., Julkunen I. Hepatitis C virus proteins interfere with the activation of chemokine gene promoters and downregulate chemokine gene expression. J. Gen. Virol. 2008, 89:432-443.
44. Sosnovtsev S.V., Belliot G., Chang K.O., Prikhodko V.G., Thackray L.B., Wobus C.E., Karst S.M., Virgin H.W., Green K.Y. Cleavage map and proteolytic processing of the murine norovirus nonstructural polyprotein in infected cells. J. Virol. 2006, 80(16):7816-7831.
45. Souza M., Cheetham S.M., Azevedo M.S., Costantini V., Saif L.J. Cytokine and antibody responses in gnotobiotic pigs after infection with human norovirus genogroup II.4 (HS66 strain). J. Virol. 2007, 81(17):9183-9192.
46. Ward V.K., McCormick C.J., Clarke I.N., Salim O., Wobus C.E., Thackray L.B., Virgin H.W., Lambden P.R. Recovery of infectious murine norovirus using pol II-driven expression of full-length cDNA. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(26):11050-11055.
47. Webb L.M., Alcami A. Virally encoded chemokine binding proteins. Mini Rev. Med. Chem. 2005, 5(9):833-848.
48. Willcocks M.M., Carter M.J., Roberts L.O. Cleavage of eukaryotic initiation factor eIF4G and inhibition of host-cell protein synthesis during feline calicivirus infection. J. Gen. Virol. 2004, 85:1125-1130.
49. Wingfield T., Gallimore C.I., Xerry J., Gray J.J., Klapper P., Guiver M., Blanchard T.J. Chronic norovirus infection in an HIV-positive patient with persistent diarrhoea: a novel cause. J. Clin. Virol. 2010, 49(3):219-222.
50. Wobus C.E., Karst S.M., Thackray L.B., Chang K.O., Sosnovtsev S.V., Belliot G., Krug A., Mackenzie J.M., Green K.Y., Virgin H.W. Replication of Norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol. 2004, 2(12):e432.
51. Wobus C.E., Thackray L.B., Virgin H.W.t. Murine norovirus: a model system to study norovirus biology and pathogenesis. J. Virol. 2006, 80(11):5104-5112.
52. Zeremski M., Petrovic L.M., Talal A.H. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J. Viral Hepat. 2007, 14(10):675-687.
53. Zhao L., Toriumi H., Kuang Y., Chen H.C., Fu Z.F. The roles of chemokines in rabies virus infection: overexpression may not always be beneficial. J. Virol. 2009, 83(22):11808-11818.